Antimetastasis therapy: Neurotensin (NT) inhibits migration, invasion and metastasis via down regulation of phosphodiesterase 7A (PDE7A), 11/May/2015, 23.48

Antimetastasis therapy: Neurotensin (NT) inhibits migration, invasion and metastasis via down regulation of phosphodiesterase 7A (PDE7A), 11/May/2015, 23.48

Antimetastasis therapy: Neurotensin (NT) inhibits migration, invasion and metastasis via down regulation of phosphodiesterase 7A (PDE7A), 11/May/2015, 23.48 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Antimetastasis therapy: Neurotensin (NT) inhibits migration, invasion and metastasis via down regulation of phosphodiesterase 7A (PDE7A), 11/May/2015, 23.48, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: 

This suggests that Neurotensin (NT), by increasing the expression of its target gene, it may suppress the expression of PDE7A.  Thereby, it may inhibit metastatic progression of human tumors. Thus, pharmacological formulations encompassing “Neurotensin (NT)  activators may be used to inhibit the progression of tumors.

Undisclosed information: How Neurotensin (NT) suppresses the expression of PDE7A

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation